Skip to content
★ Sign in to follow
NewGenIvf Group Ltd logo

NewGenIvf Group Ltd Stock: price and insider trades · United States

US·Mcap US$4.8MHealth Care

NewGenIvf Group Ltd: what insiders have been doing

NewGenIvf Group Ltd is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). Between 6 November 2025 and 6 November 2026, 2 insiders published 2 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

With 2 filings in twelve months, the company is quieter than the median of 24 filings across the 3,182 companies we follow on the same exchange.

There has been no open-market purchase by an insider of NewGenIvf Group Ltd for at least a year.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 2,338 of 26,912 companies
75.3
score / 100
Value
100
Quality
51
FCF yld·
Earn yld·
EV/EBITDA0.9x
ROE5.5%
Gross mgn20%
Net mgn·
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.49
Analyst consensus
1 analysts
·
US$4,066.56Target US$4,066.56(+834580%)US$4,066.56
Income statement
RevenueUS$4.7M
Gross profitUS$955.8k20% margin
EBITDAUS$10.8M229% margin
Net incomeUS$9.9M24.2% margin
Valuation
PER (forward)0.0x
P/Book0.0x
Beta0.17
Balance sheet & cash
Market capUS$4.8M
Total debtUS$4.9M
Free Cash Flow-US$16.7M
Debt / Equity6%
Profitability & ownership
ROE5.5%
ROA-26.9%
% insiders3.2%
% institutions0.1%
Last declaration on 6 October 2026
Declarations2 total
  • ◇
    Chairman & CEOExecutives
    30SEC
    139,811 shares100.0% of flowClass B Ordinary SharesSEC:0001213900-26-107053:0
  • ◇
    Chief Marketing OfficerExecutives
    19SEC
    139,811 shares100.0% of flowClass B Ordinary SharesSEC:0001213900-26-107052:0

2 of 2 declarations

About NewGenIvf Group Ltd

NewGenIvf Group Ltd is a company specializing in assisted reproductive technologies. It operates on the XNAS market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations